Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Ledger

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Reproductive Biomedicine Online|April 13, 2013
Clinical pharmacology of gonadotrophin preparationsWilliam Ledger
Current Opinion in Obstetrics & Gynecology|May 29, 2002
What to do about the polycystic ovary 'epidemic'William Ledger
Best Practice & Research. Clinical Obstetrics & Gynaecology|November 13, 2018
Preface - Vol. 53William Ledger
BJOG : an International Journal of Obstetrics and Gynaecology|October 17, 2019
Preimplantation genetic screening should be used in all in vitro fertilisation cycles in women over the age of 35 years: AGAINST: Pre-implantation genetic screening should not be used in all IVF cycles in women over the age of 35 yearsWilliam Ledger
Journal of Assisted Reproduction and Genetics|July 10, 2015
Letter to the editorWilliam Ledger
Journal of Assisted Reproduction and Genetics|February 19, 2013
Ovarian stimulation protocols for onco-fertility patientsJuliette Koch, William Ledger
Women'S Health (London, England)|May 12, 2016
Anti-Müllerian hormone is all you need: an assisted reproductive technology perspective in diagnosing polycystic ovary syndromeKate McCullough, William Ledger
Human Reproduction (Oxford, England)|October 11, 2011
The expression of activins, their type II receptors and follistatin in human Fallopian tube during the menstrual cycle and in pseudo-pregnancyBassem Refaat, William Ledger
Fertility and Sterility|October 4, 2011
Barriers to conducting clinical research in reproductive medicine: Australia and the United KingdomWilliam Ledger, Michael Chapman
Seminars in Fetal & Neonatal Medicine|June 17, 2014
The economic implications of multiple pregnancy following ARTGeorgina M Chambers, William Ledger
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Reproductive Biomedicine Online|April 13, 2013
Clinical pharmacology of gonadotrophin preparationsWilliam Ledger
Current Opinion in Obstetrics & Gynecology|May 29, 2002
What to do about the polycystic ovary 'epidemic'William Ledger
Best Practice & Research. Clinical Obstetrics & Gynaecology|November 13, 2018
Preface - Vol. 53William Ledger
BJOG : an International Journal of Obstetrics and Gynaecology|October 17, 2019
Preimplantation genetic screening should be used in all in vitro fertilisation cycles in women over the age of 35 years: AGAINST: Pre-implantation genetic screening should not be used in all IVF cycles in women over the age of 35 yearsWilliam Ledger
Journal of Assisted Reproduction and Genetics|July 10, 2015
Letter to the editorWilliam Ledger
Journal of Assisted Reproduction and Genetics|February 19, 2013
Ovarian stimulation protocols for onco-fertility patientsJuliette Koch, William Ledger
Women'S Health (London, England)|May 12, 2016
Anti-Müllerian hormone is all you need: an assisted reproductive technology perspective in diagnosing polycystic ovary syndromeKate McCullough, William Ledger
Human Reproduction (Oxford, England)|October 11, 2011
The expression of activins, their type II receptors and follistatin in human Fallopian tube during the menstrual cycle and in pseudo-pregnancyBassem Refaat, William Ledger
Fertility and Sterility|October 4, 2011
Barriers to conducting clinical research in reproductive medicine: Australia and the United KingdomWilliam Ledger, Michael Chapman
Seminars in Fetal & Neonatal Medicine|June 17, 2014
The economic implications of multiple pregnancy following ARTGeorgina M Chambers, William Ledger
Pageof 8